Plasma methotrexate concentrations in urothelial cancer chemotherapy

The plasma methotrexate (MTX) concentration was measured during 50 courses of chemotherapy on 26 urothelial cancer patients. A dose of 300 mg/body MTX was infused within 2 hours and plasma concentrations were measured at the scheduled times. Plasma level at the end of infusion was (2.3 +/- 0.8) x 10...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 36(1990), 9 vom: 14. Sept., Seite 991-6
1. Verfasser: Kitamura, Y (VerfasserIn)
Weitere Verfasser: Watanabe, M, Komatsubara, S, Sakata, Y
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1990
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Etoposide 6PLQ3CP4P3 Cisplatin Q20Q21Q62J Methotrexate YL5FZ2Y5U1
Beschreibung
Zusammenfassung:The plasma methotrexate (MTX) concentration was measured during 50 courses of chemotherapy on 26 urothelial cancer patients. A dose of 300 mg/body MTX was infused within 2 hours and plasma concentrations were measured at the scheduled times. Plasma level at the end of infusion was (2.3 +/- 0.8) x 10(-5) M/L, (2.9 +/- 1.9) x 10(-5) M/L at the 6th-hour, and (1.9 +/- 1.8) x 10(-7) M/L at the 24th-hour after the infusion. The plasma MTX concentration values were inversely correlated with creatinin clearance. In 6 cases of Kock pouch bladder, clean intermittent self catheterization of urine caused no meaningful increase of MTX
Beschreibung:Date Completed 21.12.1990
Date Revised 21.11.2013
published: Print
Citation Status MEDLINE
ISSN:0018-1994